|
|
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)
Ramy Rahme
,
Lionel Ades
,
Xavier Thomas
,
Agnes Guerci-Bresler
,
Arnaud Pigneux
,
et al.
Article dans une revue
hal-03605023v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Severe varicella-zoster virus pneumonia: a multicenter cohort study
Adrien Mirouse
,
Philippe Vignon
,
Prescillia Piron
,
René Robert
,
Laurent Papazian
,
et al.
Article dans une revue
hal-01573746v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau
,
Michel Attal
,
Cyrille Hulin
,
Bertrand Arnulf
,
Karim Belhadj
,
et al.
Article dans une revue
hal-03605015v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes Following Hematopoietic Stem Cell Transplantation in Patients Treated with Chemotherapy with or without Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Cécile Pautas
,
Emmanuel Raffoux
,
Juliette Lambert
,
Ollivier Legrand
,
Sylvain Chantepie
,
et al.
Article dans une revue
hal-03605017v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|